Novocure Ltd.
(NASDAQ : NVCR)

( )
NVCR After-Hours: () as of PM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Medical Specialties
symbolcompany%chnglast%shortavg$volume
MDTMedtronic PLC
1.41%86.850.6%$503.03m
ISRGIntuitive Surgical, Inc.
1.90%517.782.4%$492.65m
TMOThermo Fisher Scientific Inc.
3.08%269.611.0%$454.54m
ABTAbbott Laboratories
1.77%78.110.8%$433.21m
BDXBecton, Dickinson and Company
2.17%237.551.1%$367.84m
ALGNAlign Technology, Inc.
-0.11%296.746.3%$348.20m
BSXBoston Scientific Corporation
4.23%36.941.1%$336.20m
SYKStryker Corporation
1.16%187.191.3%$276.11m
BAXBaxter International Inc.
-0.04%76.251.7%$241.63m
EWEdwards Lifesciences Corporation
-0.30%177.191.2%$224.13m
ABMDABIOMED, Inc.
-1.00%268.133.3%$214.45m
WATWaters Corporation
2.81%213.373.5%$149.73m
DXCMDexCom, Inc.
-0.59%118.128.4%$148.16m
ZBHZimmer Biomet Holdings, Inc.
0.20%124.701.7%$146.96m
TNDMTandem Diabetes Care, Inc.
0.52%60.164.0%$109.35m

Company Profile

Novocure Ltd. is global oncology company, which engages in the development and commercialization of its innovative therapy. It focuses on the commercial adoption of Optune, and its Tumor Treating Fields delivery system, for the treatment of glioblastoma (GBM), and to advance programs testing the efficacy and safety of Optune in multiple solid tumor indications through clinical pipeline. The company was founded by Yoram Palti in 2000 and is headquartered in St. Helier, Jersey.